Thank you to the 2020 Sponsors that power Uplifting Athletes’ Young Investigator Draft


Uplifting Athletes is excited to host the 3rd Annual Young Investigator Draft Presented by CSL Behring on Saturday, March 7th at Lincoln Financial Field, home of the NFL’s Philadelphia Eagles.

The Young Investigator Draft is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.

Young Investigator Draft grants fund research that is collaborative and translational in order to positively impact treatments and potential cures for the entire Rare Disease Community. The Young Investigator Draft stage provides a platform to celebrate these scientists, the impact they are having and the importance of their research.

It takes a strong team to make the Young Investigator Draft a success, and we are grateful and proud of the 15 major sponsors on our team in 2020.

“The support that we have received for this event has worked to amplify and instill more purpose in what we do on a day-to-day basis,” Uplifting Athletes Executive Director Rob Long said. “We have great passion to do all we can to have a positive and lasting effect on the Rare Disease Community. Without this event and its sponsors our impact wouldn’t be the same.”

For the third year in a row, global biotherapeutics leader CSL Behring is the presenting sponsor of the Young Investigator Draft. Their commitment as the signature sponsor has been a game changer. 

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders.

This is the third year Sanofi-Genzyme has been a teammate. This year, Sanofi-Genzyme is a Hall of Fame sponsor. At Sanofi-Genzyme, they continue to focus on being transformative in rare diseases: developing therapies, supporting research and offering innovative solutions that have the potential to offer meaningful change to those impacted by rare diseases.

PRA Health Sciences has been a strong three-year supporter of Uplifting Athletes and the Young Investigator Draft. For 2020, PRA Health Sciences is on board as an All-Pro sponsor. PRA Health Sciences is dedicated to the future of clinical development and every life it saves.

Horizon Pharma was one of the first sponsors of the Young Investigator Draft and we are honored to have them back in year No. 3 as an All-Conference level sponsor. Horizon Pharma defines its success by a different set of numbers: the number of lives touched, the number of lives changed, the number of lives saved.

For the third year in a row Retrophin is part of the Young Investigator Draft team. At Retrophin, their mission is to identify, develop and deliver life-changing therapies to people living with rare diseases.

Spark Therapeutics was the very first sponsor of the Young Investigator Draft and we will always be grateful for their commitment to rare disease research through our event. At Spark Therapeutics their mission is to challenge the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now.

We Work For Health (WWFH) is in its third year as a sponsor and has been a strong teammate. We Work For Health is supported by PhRMA and seeks to educate elected leaders, the news media and the communities they serve about the important contributions companies and their employees make to the health and economic security of individuals, local communities, states and the nation.

Amicus Therapeutics has been on the Young Investigator Draft sponsorship team since the beginning. Amicus is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.

Ultragenyx first joined our team as a rookie sponsor of the Young Investigator Draft in 2019 and is back again. Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases.

Uplifting Athletes would like to welcome six new organizations to our Young Investigator Draft sponsorship team. Takeda, PhRMA, Ovid, Synteract, Parexel and Mallinckrodt are each 2020 rookie sponsors.

Takeda is a 2020 MVP sponsor and this patient-focused, values-based, R&D-driven global biopharmaceutical company is committed to bringing Better Health and a Brighter Future to people worldwide. Their passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.

PhRMA joins our team also as an MVP sponsor this year. PhRMA represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. PhRMA is committed to advancing public policies in the United States and around the world that support innovative medical research, yield progress for patients today and provide hope for the treatments and cures of tomorrow.

At Ovid Therapeutics, innovations come from the heart. They listen to the needs of the rare disease communities in every element of their work. With deep professional expertise in rare disease therapeutic development and commercialization, Ovid makes those innovations a reality for individuals with rare neurological diseases and their families.

Synteract is a full-service CRO that focuses on bringing clinical trials to life. Synteract is focused on supporting innovation in drug development and advancement of better therapies in healthcare to improve patients’ lives.

Parexel is in the business of improving the world’s health. Parexel does this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, their therapeutic, technical, and functional ability is underpinned by a deep conviction in what they do.

Mallinckrodt is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. Mallinckrodt provides medicines to address unmet patient needs, stemming from 150 years of using their unique strengths, experience and expertise to help improve people’s lives.

“After the great success of the first two years of the Young Investigator Draft, we are proud to once again use our platform to promote and support the brilliant minds that are conducting rare disease research.” Long said. “We are uniquely positioned to host an event where we can foster collaboration and awareness by bringing together patients, caregivers, researchers, clinicians, industry and athletes in one room.”

Uplifting Athletes has provided more than $180,000 in funding to rare disease researchers through its first two Young Investigator Drafts.

Tickets to the 2020 Young Investigator Draft are available through the registration page. The event will include stadium tours of Lincoln Financial Field, heavy hors d’oeuvres and beer and wine prior to the program for the evening.

The challenges faced by the Rare Disease Community are bigger than any one individual, team or organization can tackle alone. At Uplifting Athletes we take pride in fulfilling our mission to inspire the Rare Disease Community with hope through the power of sport with a powerful network of more than 20 college football student-athlete led chapters, Uplifting Ambassadors and Team UA participants.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s